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We began performing coronary artery bypass grafting for a large health 
maintenance organization (HMO) in 1974, as the sole provider of their cardiac 
surgery. The outcomes of our HMO group of patients were compared with 
those of our patients treated on a fee-for-service (FFS) basis. The HMO system 
entails preintervention and multidisciplinary screening conferences and is 
devoid of self-referral and personal financial incentives. Since 1985, the 
operative mortality for HMO patients has been consistently lower than for FFS 
patients. There were 8483 operations during this study period: 3168 (37%) were 
in the HMO group, with an overall operative mortality of 2.7%, and 5315 (63%) 
were in the FFS group, with an operative mortality of 4.6% (p = 0.00002). This 
difference was investigated with univariate and multivariable analyses. Sixteen 
factors were found to univariately affect he risk of operative mortality; for five 
of these risk correlates there was a significant maldistribution between the 
HMO and FFS patients. Logistic regression was used to explore the influence 
of this imbalance in risk factors. The model found seven independent risk 
factors (left ventricular failure, emergency coronary bypass, redo bypass, 
nonuse of the internal thoracic artery, unstable angina, age, and diabetes) that 
significantly affected operative mortality. The FFS group variable closely 
approached independent risk significance at p = 0.059. This multivariable 
model explained only one third of the observed ifferences in actual mortality 
between the HMO and FFS groups. The system-wide angioplasty/coronary 
bypass ratio, which could not be used in a patient-specific model, was 0.6 in the 
HMO system and 1.5 in the FFS group. Other factors related to the operating 
structure of a mature, large HMO may account for the remainder of the 
difference. The HMO referral system, through a powerful selection process, 
resulted in fewer emergencies, redo bypass operations, and catheterization 
complications that, in turn, yielded lower operative mortality than a noncoor- 
dinated FFS system of cardiovascular management. (J THORAC CARDIOVASC 
SURG 1996;111:708-17) 
p olitical and economic market forces of the past 
decade have powered major changes in the pro- 
vision of health care in the United States. This 
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health care reform has been made evident by the 
constantly increasing market share of managed care 
and capitated elivery systems, with the pure private 
practice, fee-for-service (FFS) structure playing an 
ever diminishing role. Health maintenance organi- 
zation (HMO) coverage grew from 8.3% of all 
hospital admissions to 17.0% between 1983 and 
1988 in California. 1This explosive growth of man- 
aged and capitated health care systems has since 
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spread to almost all other regions of the United 
States. 
The restructuring of medical delivery into highly 
managed, clinically coordinated systems carries with 
it significant medical and socioeconomic questions 
concerning the benefits and risks of such a change in 
the process of disease treatment. Namely, does a 
coordinated process of disease management, with 
redirected financial incentives, provide an indirect 
method of rationing that may inherently alter the 
morbidity and mortality of the treatment of a par- 
ticular disease? 
Cardiovascular sector risk contracting rowth, as 
exemplified by Medicare statistics, has mirrored the 
health care market changes with a fivefold growth to 
6% over the past 10 years. 2Even more striking is the 
progressive nature of cardiovascular health care 
delivery in the Pacific Northwest. This is exemplified 
by the Cardiology Preeminence Roundtable report, 2
which noted that 64% (10 times the national aver- 
age) of all Medicare cardiovascular services in Port- 
land, Oregon, in 1993 were capitated. Managed 
systems have gradually ascended to prominence in 
our geographic market over the past 15 years. Thus 
an unusual opportunity has presented itself during 
this transition--to test the hypothesis that a man- 
aged system of cardiovascular health care results in 
an altered risk to patients undergoing treatment for 
heart disease as compared with a pure FFS system. 
Our cardiac surgical group has performed coro- 
nary artery bypass graft (CABG) operations at 
Providence St. Vincent Hospital and Medical Cen- 
ter in Portland, Oregon, since 1968. In 1974, we 
became the exclusive provider of cardiac surgical 
services to Kaiser Permanente Health Maintenance 
Organization in Oregon and Washington. These 
surgical services were provided at the same institu- 
tion and with the same group of surgeons that 
concomitantly maintained an active tertiary referral, 
private FFS practice. By 1985, annual CABG vol- 
umes had increased to levels large enough to allow 
valid comparisons between the HMO and FFS 
groups. Annual review has shown that CABG oper- 
ative mortality has been consistently lower in the 
Kaiser HMO group of patients over the past 10 
years. 
The purpose of this investigation was to test the 
hypothesis of HMO-altered CABG risk described 
earlier and elucidate the pertinent patient- and 
system-related variables contributing to this differ- 
ence. 
# of CABG 
1200 
1000 
800 
600 
400 
200 
0 
1975 1980 1985 1990 1994 
Year 
Fig. 1. Number of CABG operations per year since 1974, 
the first year of our HMO experience. 
Patients and methods 
Patients. A total of 14,416 CABGs were performed at 
Providence St. Vincent Hospital and Medical Center 
between January 1974 and March 1994. All patients were 
operated on by the same surgical group in a common 
hospital setting. In 1985, the number of HMO CABGs per 
annum rose above 200 for the first time and has grown 
gradually (Fig. 1). Thus we chose the decade between 
January 1985 and March 1994 as the study period for a 
comparative analysis between outcomes of patients having 
CABG in an HMO or FFS setting. 
Demographic, atheterization, operative, perioperative, 
and follow-up data were extracted from our cardiac 
surgery outcomes database, which has been in active 
existence since 1972. This database is constantly updated 
with new patient and follow-up patient information. Non- 
surgical, myocardial infarction, admission, and death rates 
in 1992 and 1993 were obtained from the Kaiser Perma- 
nente and St. Vincent medical records centers. 
Definitions 
Catheterization complications. Catheterization compli- 
cations were defined as problems in the catheterization 
laboratory that necessitated urgent or emergency CABG. 
These included (1) percutaneous transluminal coronary 
angioplasty (PTCA) or attempted PTCA resulting in a 
myocardial infarction or circulatory instability, chest pain, 
or hypotension or (2) direct intracoronary thrombolytic 
therapy resulting in a myocardial infarction or circulatory 
instability. 
History of PTCA. Any patient who had had PTCA 
before the present admission was considered to have a 
history of angioplasty. 
Elective CABG. An elective operation is one that is 
performed on a patient with cardiac ischemia that is stable 
in the days or weeks before the operation. Patients 
receiving an elective operation eed not remain in the 
hospital in the interval between cardiac catheterization 
and the CABG operation. 
Urgent CABG. Any patient who does not have to go to 
the operating room on an emergency basis but requires 
CABG on the basis of medical necessity before discharge 
is considered to need urgent CABG. The patient must 
have unstable symptoms or critical anatomy and may 
require intravenous intervention (e.g., nitroglycerin, hep- 
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Fig. 2. Operative mortality per year since 1985, the first 
year our HMO CABG procedures numbered greater than 
200. 
arin, or inotropic support) for stabilization before the 
operation. These patients do not fit into the elective or 
emergency ategories. 
Emergency CABG. An emergency operation is one in 
which there should be no delay in providing operative 
intervention. Patients requiring an emergency operation 
will have ongoing, refractory, unrelenting cardiac ompro- 
mise, with or without hemodynamic instability, and are 
not responsive to any form of therapy except cardiac 
surgery. 
Most other variable definitions are self-explanatory. 
Data analysis. Statistical Package for Social Sciences 
(SPSS, Inc., Chicago, Ill.) statistical software was used to 
analyze all data. All results are expressed as mean _+ 
standard error of measurement. Univariate comparisons 
were performed with two-tailed t tests for continuous 
variables and Pearson's )(2 statistic for categoric variables. 
Bonferroni's correction for multiple analyses was applied 
to all univariate analyses by dividing the resultant p value 
by the total number of different comparisons between any 
two groups. 
Multivariable analyses were performed by means of a 
forward stepwise logistic regression. To assess the fit of 
the resultant model, we used two methods of analysis, 
both of which can be portrayed graphically. These meth- 
ods assess different properties of the model: one is called 
calibration 3 or reliability 4'5 and the second is called 
discrimination 4, 5 or resolution. 6 The first measures the 
ability of the model to assign appropriate risk. It is usually 
evaluated by dividing the patients into groups according to 
expected risk and comparing the expected mortality to the 
mortality actually observed in those groups. The second 
measures the model's ability to discriminate among those 
who die or live and can be summarized by an ROC 
(receiver operating characteristic) curve. 
Resu l ts  
A total of 8483 CABGs were performed uring 
the study period. Kaiser HMO patients accounted 
for 37% of the operations, with FFS patients making 
up the remaining 63%. Annual operative mortality 
was consistently lower for the HMO patients 
throughout the study period (Fig. 2). Overall mor- 
tality was significantly lower in the HMO group 
(2.7%; 86/3168) than in the FFS group (4.6%; 
242/5315; p < 0.0005). 
A comparison of the demographic and medical 
characteristics of these two study groups (Table I) 
reveals that most patient-related variables uch as 
age, gender, and the incidence of diabetes, hyper- 
tension, and previous infarction are strikingly simi- 
lar. Likewise, most cardiac comorbidities are also 
closely matched, including the incidence of left ven- 
tricular failure, left main trunk disease, acute myocar- 
dial infarction, and the number and type of CABGs 
used. In addition, although ahigher proportion of FFS 
patients were operated on early in the study period, 
the mean date of operation for the two groups was not 
different. However, some very important differences 
remain between the HMO and FFS populations. The 
HMO group had significantly lower rates of redo and 
emergency CABG operations and lower incidences of 
previous PTCA and catheterization laboratory compli- 
cations. Note that the HMO group also had a lower 
mean ejection fraction. 
Univariate analyses of these variables revealed sev- 
ern potential correlates of operative mortality (Table 
II). Many of these correlates of mortality concur with 
previously published independent CABG risk factors, 
including age greater than 70 years, 7-9 female gen- 
der, 7'8 diabetes, 7 redo CABG, 7' 10 left main trunk 
disease, 11 left ventricular failure, 7 acute myocardial 
infarction,& 12 emergency operation, 1°' 13 preoperative 
use of an intraaortic balloon pump]' 12 and nonuse of 
the left internal thoracic artery.16 Interestingly, both a 
history of PTCA and hyperlipidemia were shown to be 
protective against CABG mortality. 
Univariately significant variables were then used 
in a series of multivariable regression analyses to 
determine which factors were independent predic- 
tors of operative mortality. This series of tests began 
with many variables and few patients. The least 
significant variables at the end of each run were 
progressively excluded to gain a larger number of 
patients with complete sets of data available for 
inclusion in the model. The final regression model 
(Table Ill) included 3686 (43%) of the 8483 study 
patients. No significant demographic differences 
were observed between excluded patients (with one 
or more missing risk factors) and those patients 
included in the final model. As shown in Table III, 
this model revealed that left ventricular failure, 
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Table I. Patient characteristics: HMO versus FFS 
Variable HMO FFS Nominal 
p Values 
Significant 
No. of Patients 3168 5315 
Demographics 
Mean age (yr) 64 _+ 0.2 65 ± 0.1 0.0328 
Male gender (%) 73 ± 1 75 _+ 1 0.0501 
History 
Cardiomegaly (%) 11 _+ 1 10 _+ 1 0.0937 
Diabetes (%) 23 -+ 1 20 _+ 1 0.0037 
Family history of CAD (%) 43 _+ 1 48 -- 1 0.0008 
Hypertension (%) 49 -+ 1 50 -- 1 0.2588 
Hyperlipidemia (%) 26 _+ 1 27 _+ 1 0.4799 
Thrombolysis (%) 5.2 ± 0.4 4.3 _+ 0.3 0.0422 
Digitalis plus diuretics (%) 3.1 ± 1 3.4 _+ 1 0.5812 
Previous MI (%) 29 ± I 30 ± 1 0.2406 
Previous CABG (%) 12 ± 1 18 ± 1 0.0000 
Previous PTCA (%) 7.1 + 0.4 9.3 -- 0.4 0.0004 
Catheterization i formation 
Ejection fraction (%) 56 _+ 0.6 60 -- 0.3 0.0000 
Wall motion abnormality 44 _+ 4 53 ± 3 0.0000 
(~) 
Mean No. of diseased ar- 2.7 _+ 1.7 2.6 ± 1.3 0.0001 
teries 
Left main disease (%) 20 _+ 1 20 _+ 1 0.9911 
Indications 
LV failure (%) 1.8 _+ 0.3 2.6 +_ 0.3 0.0677 
Acute MI < 30 days (%) 14 ± 2 16 ± 2 0.1582 
Stable angina (%) 42 ± 3 45 _+ 2 0.0206 
Elective (%) 86 _+ 0.7 81 ± 0.6 0.0000 
Emergency (%) 6.5 _+ 0.5 10.4 ± 0.5 0.0000 
Catheterization complica- 2.7 + 0.4 6.8 ± 0.5 0.0000 
tion (%) 
Surgical factors 
Mean year of operation 1990.0 ± 0.05 1989.8 ± 0.04 
Preop IABP (%) 0.9 ± 0.4 2.7 _+ 0.5 0.0071 
ITA used (%) 57 _+ 0.9 56 ± 0.7 0.2074 
Mean No. of grafts 2.7 _+ 0.02 2.7 ± 0.01 0.9983 
Yes 
Yes 
Yes 
Yes 
Yes 
Yes 
Yes 
Yes 
Yes 
CAD, Coronary artery disease; M/,, myocardial infarction; LV, left ventricular; IABP, intraaortic balloon pumping; ITA, internal thoracic artery. 
*Univariate analyses with Bonferroni correction applied to determine significance. The p value required for significance = 0.05/25 = 0.0020. 
emergency operation, redo CABG, nonuse of the 
internal thoracic artery, unstable angina, age, and 
diabetes were independent predictors of periopera- 
tire CABG mortality. In this multivariate analysis, 
FFS was not a significant independent predictor of 
risk but showed a strong trend toward significance, 
with ap value of 0.059 in the final model. Among the 
3686 patients included in the final regression model, 
the operative mortalities of the HMO and FFS 
subgroups of patients were 2.6% (33/1279) and 
4.1% (98/2407), respectively (p < 0.02). 
The clinical outcome deviance (the negative of 
2× the log likelihood) decreased from 1132 for the 
null model (step 0 of the multivariable regression) 
to 924 for the final regression model (step 7). This 
difference of 208 was highly significant (p < 0.00001, 
with 7 degrees of freedom), indicating that the 
model did improve the ability to predict outcome. 
However, this particular model decreased the orig- 
inal deviance by only 18%. Thus other important 
variables not included in the model contribute to 
mortality. This result is not uncommon, in a pragmatic 
sense, for a predictive clinical outcomes model. 
Indices of callibration and discrimination were 
used to assess the predictive accuracy of the logistic 
regression model. The patients were divided into ten 
groups of approximately equal numbers on the basis 
of the deciles of estimated operative mortality. Fig. 
3 compares the average stimated mortality (hori- 
zontal axis) with the observed mortality (vertical axis) 
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Table II. Operative mortality by patient 
characteristics 
Motlality p Values 
Present Absent 
Variable (%) (%) Nominal Significant 
FFS patient 2.7 4.6 0.0000 Yes 
Age >70 yr 6.2 2.7 0.0000 Yes 
Female gender 5.3 3.4 0.0000 Yes 
History 
Cardiomegaly 7.7 3.0 0.0000 Yes 
Diabetes mellitus 5.1 3.5 0.0022 Yes 
Family history 3.2 3.9 0.1539 
of CAD 
Hypertension 4.3 3.3 0.0135 
Hyperlipidemia 2.6 4.3 0.0003 Yes 
Thrombolysis 5.1 3.8 0.1899 
Digitalis plus diuretic 6.9 3.8 0.027l 
MI 4.4 3.6 0.0879 
Previous CABG 7.5 3.2 0.0000 Yes 
Previous PTCA 1.4 4.1 0.0004 Yes 
Catheterization 
information 
Wall motion 4.8 2.3 0.0000 Yes 
abnormality 
Left main trunk 6.0 3.5 0.0013 Yes 
Indications 
Left heart failure 15.1 3.4 0.0000 Yes 
Acute MI (<30 days) 8.5 3.3 0.0000 Yes 
Unstable angina 5.4 1.7 0.0000 Yes 
Emergency 12.0 2.8 0.0000 Yes 
operation 
Catheterization 11.2 3.5 0.0000 Yes 
complication 
Surgical factors 
Preop. IABP 44.4 3.6 0.0000 Yes 
ITA used 1.8 6.6 0.0000 Yes 
CAD, Coronary artery disease; MI, myocardial infarction; IABP, intraaor- 
tic balloon pump; ITA, internal thoracic artery. 
*Univariate analyses with Bonferroni correction applied to determine 
significance. The p value required for significance = 0.05/22 - 0.0023. 
within each group. The value of the Hosmer- 
Lemeshow test statistic TM was 0.77, indicating a 
good fit to the data. Fig. 4 contains the ROC curve 
derived from the model. The area under the curve 
(called the c-index) of 83% measures the proba- 
bility that a randomly chosen death would have a 
higher expected mortality than a randomly chosen 
survival. 
Long-term follow-up was completed between 1992 
and 1994 on 6532 (77%) patients at a mean of 30 
months after the operation. Kaplan-Meier survival 
analysis (Fig. 5) revealed no significant difference (p = 
0.09) between the HMO and FFS patient populations 
through 9 years after the operation. Thus, despite a 
reduction in perioperative mortality, the HMO selec- 
Table IlL Multivariable risk factor analysis 
Risk factor 
Odds ratio 
p Value Point Est. 95% CI ~-coefficient 
LV failure 0.0000 4.5 (2.2, 9.1) 1.5 
Emergency operation 0.0000 4.3 (2.8, 6.9) 1.5 
Previous CABG 0.0000 3.1 (2.0, 4.7) 1.1 
ITA not used 0.0000 2.7 (1.7, 4.2) 0.98 
Unstable angina 0.0001 2.5 (1.6, 4.0) 0.93 
Age (per decade) 0.0000 1.9 (1.5, 2.3) 0.62 
Diabetes 0.0190 1.6 (1.1, 2.5) 0.50 
FFS 0.0599 None 
CI, Confidence interval; LV, left ventricular; ITA, internal thoracic artery. 
tion process had no significantly demonstrable effect 
on long-term CABG outcomes in operative survivors. 
Discussion 
The implication that the type of health care 
system in which cardiovascular services are provided 
may itself affect he short-term outcome of coronary 
revascularization is indeed provocative. To try to 
understand the mechanism of such an alteration in 
risk, one must dissect he respective paradigms of 
cardiovascular management in each system. 
HMO system. The Kaiser HMO system uses an 
integrated approach to the delivery of cardiovascu- 
lar services. The cardiac section is a high-volume 
service, experienced in the methods of coordinated 
care. Characteristics integral to this approach are as 
follows: 
• A prospective interdisciplinary triage conference 
for all prospective cardiovascular interventions, 
both surgical and interventional, is mandatory. 
• Retrospective case reviews are for emergencies 
only. 
• A standard treatment protocol is in place for the 
selection of patients for surgery and PTCA (see 
appendix). 
• Surgical referral is to a group of surgeons as a 
whole rather than to a specific individual surgeon. 
• Cardiologic self-referral for PTCA is nonexistent. 
All PTCA cases are passed through the interdis- 
ciplinary triage conference to a third-party inva- 
sive cardiologist. This cardiologist is specifically 
employed to perform all catheterization labora- 
tory interventions for the HMO group of patients. 
FFS system. Providence St. Vincent Hospital and 
Medical Center is a high-volume tertiary cardiac 
referral center with one cardiothoracic surgical 
group and up to 10 individually practicing cardiolo- 
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Fig. 3. Calibration assessment of the logistic regression model: expected versus observed mortality for 
deciles of expected risk. 
gist groups during this study period. Thus cardio- 
vascular services are provided in a nonintegrated, 
disparate management system in which FFS reim- 
bursement predominates. In contrast o the HMO, 
the FFS system characteristics include the following: 
• There is no prospective interdisciplinary triage 
conference for surgical, interventional, or medical 
therapy. 
• Retrospective and anecdotal case analysis is re- 
served for quality improvement only. 
• Treatment protocols are cardiologist specific, not 
written down, and may dynamically vary over 
time. 
• Referrals are surgeon specific and are subject o 
the cardiologist's discretion. 
• Cardiologists may self-refer cases for PTCA with- 
out prior case review. 
Coordination, redirected financial incentives, and 
mandatory triaging of HMO patients requiring 
CABG or PTCA drive a selection process that 
results in a CABG patient population that is signif- 
icantly and clinically different from the FFS cohort. 
Two of these differences--emergency operation and 
redo CABG--directly contribute, as strong inde- 
pendent factors, to a lower CABG mortality in the 
HMO group. 
Although referral source, per se, was not found to 
be a strict independent predictor of mortality in this 
model, it is highly likely that it would come into the 
equation with more complete data by allowing a 
larger multivariable cohort for analysis. The FFS 
"risk factor" is the only univariate factor that 
"trends" toward significance, with ap value of 0.059. 
Thus more patients with similar characteristics 
would eventually bring the p value of FFS as an 
independent risk factor below the strict 0.05 cutoff. 
Using the multivariate model described herein, 
one can compare the predicted and actual mortali- 
ties in the two cohorts. The predicted mortalities for 
the FFS and HMO groups are 3.7% and 3.2%, 
respectively, giving a predicted difference of 0.5%. 
The actual mortalities in the same cohorts were 
4.1% and 2.6%, respectively, for an actual mortality 
difference of 1.5 %. Thus the multivariate model fails 
to account for a full 1.0%, or two thirds of the total 
(1.0%/1.5%) mortality difference. This unaccounted 
mortality difference favors the HMO group and 
further suggests the eventual inclusion of FFS as a 
strict independent risk factor. 
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A possible contributor to this unaccounted mor- 
tality difference is the discrepancy in the use of 
PTCA between the FFS and HMO systems (Fig. 6). 
There is a profound difference in the ratio of 
PTCA/CABG use between the FFS and HMO 
systems (1.5 vs 0.6, p < 0.00001). This factor could 
not be directly entered into the analysis of risk for 
CABG because it pertains to each system's cardiac 
population as a whole and not to any individual 
patient. Nonetheless, possible overuse of PTCA in 
the FFS system, catalyzed by self-referral, direct 
financial incentives, and possible direct referral of 
high-risk PTCA cases to this tertiary center, may 
indirectly affect CABG mortality. This is likely 
through an increased incidence of both catheteriza- 
tion complications and emergency operations in 
patients having PTCA. 
The Kaiser HMO practice guidelines for selection 
of patients for CABG and PTCA are similar to 
those of the Coronary Artery Surgery Study ran- 
domized prospective study, which have the potential 
to delay surgery in some patients with ischemia. 
However, the highly honed HMO selection process 
for interventional cardiac procedures did not result 
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in a higher mortality from nonsurgical myocardial 
infarction in the Kaiser HMO group as a whole. The 
most recent data available from the Kaiser HMO 
and St. Vincent Hospital show similar mortality 
from myocardial infarction admissions in both 1993 
(7.3%, 50/682 vs 7.1%, 54/758) and 1994 (7.2%, 
52/724 vs 8.3%, 60/724), respectively. Therefore, the 
reduction in CABG mortality through the HMO 
selection process was not achieved at the expense of 
a higher mortality resulting from medically treated 
myocardial infarctions. 
Limitations of this study include the comparison 
of a finite population (Kaiser HMO)  with an indef- 
inite population lacking a known denominator. 
Thus, although the mortality from myocardial in- 
farction is similar, one cannot compare the inci- 
dence of myocardial infarction between the two 
population groups. Furthermore, St. Vincent Hos- 
pital and Medical Center has long been a tertiary 
cardiac referral center whose cardiologists and sur- 
geons accept difficult cases from a four-state area. 
This referral group, which tends to be high risk, 
could easily skew the results against he FFS cohort. 
However, the independent risks associated with this 
referral group should be factored out by the multi- 
variable regression analysis. 
Despite these limitations, this analysis leads to the 
inescapable but provocative conclusion that referral 
source contributes to clinical and population differ- 
ences that combine to produce a lower mortality in 
a coherently managed group of patients needing 
CABG. This suggests that the coordination that 
occurs between the primary care physician, internist, 
cardiologist, and surgical team provides a safer 
pathway for patient movement through a cardiovas- 
cular service that culminates in the application of 
coronary revascularization. This continuity of care is 
the hallmark of a coordinated system which, through 
a variety of factors, reduces the mortality of coro- 
nary revascularization. Coordination, redirected fi- 
nancial incentives, and mandatory triage are the 
cornerstones of this system. 
The importance of this conclusion is that it argues 
against he concept hat capitated elivery of health 
care is primarily focused on reducing use and thereby 
is not beneficial to the patient. On the contrary, we 
have shown that Kaiser HMO participation may have 
been protective against CABG mortality. Coordi- 
nated, coherent cardiac are may certainly be possible 
in an FFS system, outside of an HMO format, that 
may achieve similar benefits to those provided by a 
tightly managed HMO structure. 
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Fig. 6. Use of CABG and PTCA for HMO and FFS 
groups by year. Top two lines = FFS system; bottom two 
lines = HMO system. 
Nevertheless, in this limited experience, a man- 
aged system of cardiovascular health provision re- 
sults in a lowered risk to patients undergoing treat- 
ment for heart disease as compared with a pure FFS 
system. 
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Discussion 
Dr. Thomas A. Pfeffer (Los Angeles, Calif.). You are 
probably in a unique position to perform a comparison 
such as this because you have a large number of patients 
in both the FFS and HMO settings. 
At Southern California Kaiser Permanente, which is the 
largest HMO in Southern California, we have, I think, 
carried your coherent system one stage further in that 
there is no contract with an outside hospital for cardiac 
procedures. All adult cardiac operations are performed in 
house by four senior cardiac surgeons, excluding the San 
Diego region, and all pediatric cases from Southern 
California, including San Diego, as well as from Hawaii, 
are performed in house. 
There is no financial incentive for the surgeons or the 
cardiologists to perform procedures; on the other hand, 
this is not a managed care system in which there is a 
potential for financial disincentive or for a potential 
gatekeeping system possibly restricting access to proce- 
dures. 
Our 1994 caseload at Southern California Kaiser com- 
prised 1639 procedures, of which 896 were CABG proce- 
dures. In comparing the cardiac characteristics of our 
series with those of yours, the incidence of redo CABGs 
was slightly lower, approximately 10% in our group, the 
incidence of recent myocardial infarction greater, approx- 
imately 20%, and the use of an internal thoracic artery as 
a conduit was more frequent. 
Our 1994 mortality for CABG was 2.2%. 
Dr. Starr, do you think there is a difference in rate of 
CABGs performed per population in the two groups of 
patients that you have? Second, inasmuch as there is no 
self-referral to cardiologists for PTCA, are these proce- 
dures performed on a contract basis with outside cardiol- 
ogists or are they performed by the HMO cardiologists? 
Third, what accounts for the difference in the rate of 
emergency operations in these two groups? 
Dr. Starr. The results of the large Kaiser group in 
California is very pertinent to this discussion. The PTCA 
is not farmed out by Kaiser but is done by an in-house 
cardiologist who is referred by other cardiologists to do 
the PTCA. Also, the number of PTCAs that are done by 
the Kaiser cardiologist, per cardiologist, is much higher 
than in the FFS system, these cardiologists are more 
experienced. 
There are no financial incentives within our system. We 
have a capitated surgical portion of the Kaiser program. 
Within a managed care system it is possible to achieve a 
significantly decreased overall mortality from CABG. The 
decrease in emergency surgery may be one of the impor- 
tant determinants of that difference. I believe that the 
decrease in emergencies is related to a more conservative 
management of acute infarction, which does not result in 
an increased incidence of death from infarction, and from 
a more judicious use of PTCA, which is markedly different 
in the two systems. 
The use of CABG in the Kaiser system is about 100 
cases per 100,000 population, which is about the same as 
the Oregon population in general. This is a high rate of 
use, but Oregon is also a high user of CABG in relation to 
other parts of the country, both being comparable. 
In addition, as we examined the population of the 
Kaiser-insured population versus the population of Ore- 
gon matched for age and sex, it matched completely with 
the age and sex distribution of the Oregon population. So 
this is not a very unusual population within Kaiser. 
Dr. Richard M. Engelman (Springfield, Mass.). Was 
there a difference in the age population of the two groups 
of patients that you investigated? 
Dr. Start. No, there was no difference in age, sex, 
hypertension, or diabetes. There were just a few elements 
that were different in each group, and they pertained 
mostly to cardiac emergencies. 
Dr. Richard P. Anderson (Seattle, Wash.). The hypoth- 
esis of this study is that the so-called "coherent" system of 
prereferral HMO cardiology management results in a 
lower operative mortality than the so-called "chaotic" 
system of prereferral non-HMO cardiology management. 
The differences between the two systems are stated to be 
preintervention screening conferences, absence of self- 
referral, and personal financial incentives. I am a believer 
in managed care systems, but I do not understand how 
differences in these matters independently affect surgical 
results. 
It is not clear whether HMO referral is an indepen- 
dent predictor of operative mortality. Multiple logistic 
regression analysis should answer this question. Has 
such an analysis or a comparable analysis been done? If 
the results show that HMO referral is an independent 
predictor of surgical mortality, then would you specu- 
late on the physiologic basis for this conclusion? On the 
other hand, if such an analysis failed to show that HMO 
membership is an independent predictor of mortality, 
then one might reasonably conclude that the HMO 
merely refers patients in whom the risk is low. In that 
event, could you speculate on HMO enrollment prac- 
tices that would result in referral of a low-risk group of 
patients who then have a lower operative mortality? 
Dr. Starr. These are excellent questions that help clarify 
the issues. With regard to the triage preintervention 
conference, the FFS practice is a truly unstructured 
practice; there is no other mechanism than an individual 
phone call from an individual cardiologist to an individual 
surgeon. That surgeon is free to accept he patient on his 
own judgment according to the Hippocratic oath. 
With regard to the reason for this HMO effect, there is no 
question that there is a difference in operative mortality, but 
how is this difference achieved? It is achieved in part by a 
selection process. This selection process avoids emergency 
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surgery to a greater extent han in the FFS practice, but it 
does not do so at the expense of a higher mortality from 
myocardial infarction. That is an important point. 
Through this selection process, without encompassing 
any higher medical mortality, the results are achieved in 
part. But the logistic regression is not significant for just 
HMO alone as an independent predictor on a multivariate 
analysis. It comes close, immediately after diabetes. We 
think if we had a larger series it would be an independent 
predictor. If it were an independent predictor, then there 
may be some other mechanisms, that is, the appropriate 
timing of operation, the integration between the primary 
care physician and the cardiologist, and the integration 
between the cardiologist and the surgeon, all resulting in 
a smoother pathway for the patient hat results in a lower 
overall operative risk. 
Whether it is an independent predictor or not, there is 
no question that one system yields a group of patients for 
whom the operative mortality is distinctly lower without 
incurring a higher medical mortality. 
Appendix :  Card iac  surgery /PTCA criter ia 
Procedure to evaluate medical necessity for cardiac 
surgery/PTCA 
A. Criteria used for CABG: 
1. Coronary angiography shows left main disease 
with greater than 50% stenosis. 
2. The patient is undergoing primary cardiac valvu- 
lar surgery and angiogram shows left main or 
one-, two-, or three-vessel disease. 
3. The patient has angina with two- or three-vessel 
disease and left ventricular dysfunction with an 
ejection fraction less than 50%. 
4. The patient has had an episode of unstable angina 
within 3 months that responded to inpatient med- 
ical management and now has recurrent angina 
despite medical therapy consisting of nitrates, 
/3-adrenergic blockers, and calcium channel 
blockers, and angiogram shows at least two-vessel 
disease. 
B. Criteria used for PTCA: 
1. Acute myocardial infarction with failed reperfu- 
sion with thrombolytic agents. 
2. Acute myocardial infarction with severe residual 
stenosis in a single vessel after successful throm- 
bolytic reperfusion. 
3. Unstable angina with near complete occlusion or 
high-grade stenosis in one- or two-vessel disease. 
4. Stable angina persisting despite antianginal ther- 
apy, and 
a. high-grade single or double vessel stenosis, or 
b. stenosis in one vessel and occlusion in another, 
or 
c. high-grade stenosis in a CABG 
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